Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Accelerate Diagnostics, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AXDX
Nasdaq
3840
acceleratediagnostics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Accelerate Diagnostics, Inc.
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results
- Jan 10th, 2025 9:05 pm
Q3 2024 Accelerate Diagnostics Inc Earnings Call
- Nov 8th, 2024 2:15 pm
Accelerate Diagnostics Inc (AXDX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
- Nov 8th, 2024 7:28 am
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates
- Nov 7th, 2024 10:40 pm
Accelerate Diagnostics: Q3 Earnings Snapshot
- Nov 7th, 2024 9:32 pm
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
- Nov 7th, 2024 9:05 pm
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results
- Oct 25th, 2024 8:30 pm
Accelerate Diagnostics Inc (AXDX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
- Oct 9th, 2024 9:56 pm
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System
- Oct 1st, 2024 4:12 pm
FDA approves Accelerate Arc system to identify microbial infections
- Oct 1st, 2024 10:33 am
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
- Sep 30th, 2024 1:15 pm
Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial
- Aug 14th, 2024 2:05 pm
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates
- Aug 8th, 2024 9:45 pm
Accelerate Diagnostics: Q2 Earnings Snapshot
- Aug 8th, 2024 8:41 pm
Accelerate Diagnostics Reports Second Quarter 2024 Financial Results
- Aug 8th, 2024 8:05 pm
Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial
- Aug 8th, 2024 8:00 pm
Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results
- Aug 8th, 2024 3:09 pm
Ekso Bionics (EKSO) Reports Q2 Loss, Lags Revenue Estimates
- Jul 29th, 2024 9:45 pm
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript
- May 9th, 2024 4:28 pm
Q1 2024 Accelerate Diagnostics Inc Earnings Call
- May 9th, 2024 10:04 am
Scroll